WallStSmart

Anheuser Busch Inbev NV ADR (BUD)vsFomento Economico Mexicano (FMX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Fomento Economico Mexicano generates 1294% more annual revenue ($872.84B vs $62.61B). BUD leads profitability with a 14.9% profit margin vs 3.6%. BUD appears more attractively valued with a PEG of 1.65. BUD earns a higher WallStSmart Score of 67/100 (B-).

BUD

Strong Buy

67

out of 100

Grade: B-

Growth: 6.7Profit: 7.0Value: 4.7Quality: 4.5
Piotroski: 5/9Altman Z: 1.25

FMX

Buy

54

out of 100

Grade: C-

Growth: 6.0Profit: 5.5Value: 4.3Quality: 5.5
Piotroski: 5/9Altman Z: 2.38
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BUDSignificantly Overvalued (-21.7%)

Margin of Safety

-21.7%

Fair Value

$63.48

Current Price

$78.23

$14.75 premium

UndervaluedFair: $63.48Overvalued

Intrinsic value data unavailable for FMX.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BUD5 strengths · Avg: 8.6/10
EPS GrowthGrowth
124.9%10/10

Earnings expanding 124.9% YoY

Market CapQuality
$158.22B9/10

Large-cap with strong market position

P/E RatioValuation
17.3x8/10

Attractively priced relative to earnings

Operating MarginProfitability
27.3%8/10

Strong operational efficiency at 27.3%

Free Cash FlowQuality
$3.84B8/10

Generating 3.8B in free cash flow

FMX2 strengths · Avg: 9.0/10
EPS GrowthGrowth
107.5%10/10

Earnings expanding 107.5% YoY

Free Cash FlowQuality
$1.44B8/10

Generating 1.4B in free cash flow

Areas to Watch

BUD3 concerns · Avg: 3.3/10
PEG RatioValuation
1.654/10

Expensive relative to growth rate

Price/BookValuation
9.9x4/10

Trading at 9.9x book value

Altman Z-ScoreHealth
1.252/10

Distress zone — elevated risk

FMX3 concerns · Avg: 2.7/10
Profit MarginProfitability
3.6%3/10

3.6% margin — thin

Debt/EquityHealth
1.173/10

Elevated debt levels

PEG RatioValuation
4.842/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : BUD

The strongest argument for BUD centers on EPS Growth, Market Cap, P/E Ratio. Revenue growth of 11.0% demonstrates continued momentum.

Bull Case : FMX

The strongest argument for FMX centers on EPS Growth, Free Cash Flow.

Bear Case : BUD

The primary concerns for BUD are PEG Ratio, Price/Book, Altman Z-Score.

Bear Case : FMX

The primary concerns for FMX are Profit Margin, Debt/Equity, PEG Ratio. Thin 3.6% margins leave little buffer for downturns.

Key Dynamics to Monitor

BUD carries more volatility with a beta of 0.78 — expect wider price swings.

BUD is growing revenue faster at 11.0% — sustainability is the question.

BUD generates stronger free cash flow (3.8B), providing more financial flexibility.

Monitor BEVERAGES - BREWERS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

BUD scores higher overall (67/100 vs 54/100) and 11.0% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Anheuser Busch Inbev NV ADR

CONSUMER DEFENSIVE · BEVERAGES - BREWERS · USA

Anheuser-Busch InBev SA / NV is engaged in the production, distribution and sale of beer, alcoholic beverages and soft drinks worldwide.

Fomento Economico Mexicano

CONSUMER DEFENSIVE · BEVERAGES - BREWERS · USA

Fomento Econmico Mexicano, SAB de CV, is a bottler of Coca-Cola brand beverages. The company is headquartered in Monterrey, Mexico.

Want to dig deeper into these stocks?